LAS VEGAS, NV–Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), a development stage company focused on the commercialization of therapeutic devices for patients living with diseases such as diabetes, is pleased to provide its shareholders with an update…